User:Paul Anders Fronth Nyhus: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
 
(19 intermediate revisions by the same user not shown)
Line 5: Line 5:


*Paul Anders Fronth Nyhus
*Paul Anders Fronth Nyhus
*NorBioS@mac.com
*NorBioS
*SynBiOSyS
*Norwegian.Igem.Team
*Europe  
*Europe  
*[[Special:Emailuser/Paul Anders Fronth Nyhus|Email me through OpenWetWare]]
*[[Special:Emailuser/Paul Anders Fronth Nyhus|Email me through OpenWetWare]]


I work in the [Open LAB ] at XYZ University.  I learned about [[OpenWetWare]] from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a framework and voluntary code of conduct for dealing proactively with Biorisks ,  Biosafety ,  Biosecurity and Biodiversity issues in  Synthetic Biology and Combinatorial Genomics .Herein included Economic,  Ethical,  Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences and avoid luddism and complete rejection from civil society.
I work in the [Open LAB ] at XYZ University.  I learned about [[OpenWetWare]] from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a coherent analytical framework for understanding the long term risks in relation to genetic engeneering and voluntary codes of conduct for dealing proactively with Biorisks ,  Biosafety ,  Biosecurity and Biodiversity Acces Benefit Sharing issues in  Synthetic Biology Metabolic engennering  Combinatorial Genomics and genome editing .Herein included Economic,  Ethical,  Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer  luddism and complete rejection from civil society.


 
Discussing the options by  inclusion and involvement of stakeholders sui generis:Cui Bene
 
Discussing the options by  inclusion and involvement of stakeholders sui generis
 
http://www.synbiosafe.eu/


==Education==
==Education==
Line 25: Line 23:
==Research interests==
==Research interests==
<!-- Feel free to add brief descriptions to your research interests as well -->
<!-- Feel free to add brief descriptions to your research interests as well -->
# Comparative genomics of Aquaporins
# Comparative genomics of Aquaporins and gene regulation
# Comparative genomics proteomics and metabolomics of Photosytnhesis /E-Photosynthesis  
# BioPatways2Bioprocess Green Chemistry Cell Free Systems and scaffolds
# Comparative genomics of gene regulatory networks
# MarineMicrobiomics Comparative genomics proteomics and metabolomics of Photosynthesis  /E-Photosynthesis /Quantum Effects in Biology
# Evolution & Develeopment ( Evo Devo)
# Comparative genomics of gene regulatory networks  
# Converging technologies
# Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz)  
# Converging technologies ( Bits Atoms Neurons & Genes )
# Neuromorphic computing deep learning /machinelearning and modelling as applied to life sciences /sequence structures functions and roles


==Useful links==
==Useful links==
http://www.cdc.gov/OD/ohs/biosecurity_training/
http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[Help|OpenWetWare help pages]]
*[[Help|OpenWetWare help pages]]
Line 39: Line 42:
* http://www.patentlens.net/daisy/patentlens/patentlens.html
* http://www.patentlens.net/daisy/patentlens/patentlens.html
* http://www.opbw.org/
* http://www.opbw.org/
One of the major challenges ahead is Antibiotics resistance
How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/
Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ?
http://www.gmo-compass.org
http://www.who.int/drugresistance/whonetsoftware/en/
http://www.fda.gov/Fdac/features/795_antibio.html
http://www.who.int/mediacentre/factsheets/fs194/en/

Latest revision as of 03:06, 3 January 2019

I am a new member of OpenWetWare!

Contact Info

Paul Anders Fronth Nyhus (an artistic interpretation)

I work in the [Open LAB ] at XYZ University. I learned about OpenWetWare from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a coherent analytical framework for understanding the long term risks in relation to genetic engeneering and voluntary codes of conduct for dealing proactively with Biorisks , Biosafety , Biosecurity and Biodiversity Acces Benefit Sharing issues in Synthetic Biology Metabolic engennering Combinatorial Genomics and genome editing .Herein included Economic, Ethical, Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer luddism and complete rejection from civil society.

Discussing the options by inclusion and involvement of stakeholders sui generis:Cui Bene

Education

  • Year, PhD, Institute
  • Year, MS, Institute
  • Year, BS, Institute

Research interests

  1. Comparative genomics of Aquaporins and gene regulation
  2. BioPatways2Bioprocess Green Chemistry Cell Free Systems and scaffolds
  3. MarineMicrobiomics Comparative genomics proteomics and metabolomics of Photosynthesis /E-Photosynthesis /Quantum Effects in Biology
  4. Comparative genomics of gene regulatory networks
  5. Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz)
  6. Converging technologies ( Bits Atoms Neurons & Genes )
  7. Neuromorphic computing deep learning /machinelearning and modelling as applied to life sciences /sequence structures functions and roles

Useful links

http://www.cdc.gov/OD/ohs/biosecurity_training/ http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm

One of the major challenges ahead is Antibiotics resistance How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? http://www.gmo-compass.org http://www.who.int/drugresistance/whonetsoftware/en/ http://www.fda.gov/Fdac/features/795_antibio.html http://www.who.int/mediacentre/factsheets/fs194/en/

Retrieved from "https://openwetware.org/mediawiki/index.php?title=User:Paul_Anders_Fronth_Nyhus&oldid=1056551"